Profil Financier
Mahima Datla occupe actuellement le rang #1408 du classement mondial StarFortune (secteur santé & biotech). Fortune nette estimée : $3.0 B (+$215 sur 24h).
Mahima Datla is the managing director of Biological E., a privately held vaccine producer, in which she holds a controlling stake.
The Hyderabad-based company's portfolio includes Corbevax, a Covid-19 vaccine developed in partnership with Texas Children's Hospital Center for Vaccine Development and Baylor College of Medicine in Houston.
Biological E. has 10 vaccines pre-qualified by the World Health Organization including those against polio, tetanus and measles. It exports vaccines to more than 130 countries.
Biological E. was founded in 1953 by her paternal and maternal grandfathers.
In 2025, Bioligcal E. struck a licensing agreement with China's Jiangsu Recbio Technology to manufacture and commercialize HPV vaccines to combat cancer.
Datla has a bachelor's degree in business management from London's Webster University. She became managing director in 2013.
In 2022, she won a nearly decade-long battle with her mother over the company's ownership that went up to India's Supreme Court.